Iowa Senate Bill SF501

Iowa 2025-2026 Regular Session

• Filed/Introduced: 3/10/25
• Introduced: 3/4/25
• Refer: 3/4/25

Caption

A bill for an act relating to medical assistance program and Hawki program coverage for standard fertility preservation services.

Summary

SF 501 would require Iowa’s Department of Health and Human Services to seek any federal approval needed to add coverage for “standard fertility preservation services” under both the state Medicaid program (medical assistance) and the Hawki program. The bill defines those services by reference to professional guidelines from the American Society for Reproductive Medicine and the American Society of Clinical Oncology, and it applies to people facing medical treatment or conditions that are expected to threaten fertility, such as surgery, radiation, chemotherapy, medication therapy, or other recognized treatments. The covered services would include procedures such as oocyte retrievals and embryo transfers, with the bill specifically allowing up to three completed oocyte retrievals and unlimited embryo transfers consistent with ASRM guidance, including single-embryo transfer when medically appropriate. Coverage would begin only after federal approval of any necessary state plan amendment or waiver, but once approved the programs would be required to provide the benefit immediately.

Impact

The bill would amend Iowa law by creating a new section in chapter 249A governing fertility preservation coverage in Medicaid and Hawki. It would expand potential benefits for eligible enrollees who face infertility risk from medically necessary treatment, and it would require the state to pursue federal authorization before implementation. The practical effect would be to add a new covered reproductive health benefit for low-income adults and children enrolled in these public programs, subject to federal matching and approval requirements.

Sentiment

Based on the bill text and the absence of recorded committee testimony or votes in the provided materials, the overall sentiment appears supportive and policy-driven, with the bill framed as a health coverage expansion rather than a controversial restructuring. The measure is presented in straightforward terms and uses established clinical guidelines, suggesting an effort to align coverage with accepted medical practice. No formal opposition, amendments, or recorded vote totals are included in the available context.

Contention

The main points of potential contention are likely to be cost, scope of coverage, and the use of public funds for fertility-related services. Because the bill requires Medicaid and Hawki coverage for oocyte retrievals and embryo transfers, some lawmakers or stakeholders could question fiscal impact, eligibility limits, or whether the benefit should extend to multiple retrievals. Another possible issue is that implementation depends on federal approval, so the state’s ability to deliver the benefit would hinge on CMS action and any waiver or state plan amendment process.